Blinatumoab公司
医学
内科学
化疗
肿瘤科
淋巴细胞白血病
白血病
作者
Inge M. van der Sluis,Paola De Lorenzo,Rishi S. Kotecha,Andishe Attarbaschi,Gabriele Escherich,Karsten Nysom,Jan Starý,Alina Ferster,Benoît Brethon,Franco Locatelli,Martin Schrappe,Peggy E. Scholte-van Houtem,Maria Grazia Valsecchi,Rob Pieters
标识
DOI：10.1056/nejmoa2214171
摘要
Blinatumomab added to Interfant-06 chemotherapy appeared to be safe and had a high level of efficacy in infants with newly diagnosed KMT2A-rearranged ALL as compared with historical controls from the Interfant-06 trial. (Funded by the Princess Máxima Center Foundation and others; EudraCT number, 2016-004674-17.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
学术文献互助
GingerF
无极微光
邓佳鑫Alan
OsamaKareem
无忧
2052669099
科研狗
仰望喀纳斯的星空
竹忆
Moonpie
iNk
lyn
单纯的富
dde
pcr163
难过的谷芹
arniu2008
乐空思
eric888
皖公网安备34019202002308
